先天性肾上腺皮质增生症21羟化酶缺乏型患者终身高的研究进展
冯韵霖，潘慧 冯韵霖、潘慧，中国医学科学院 北京协和医学院(清华大学医学部) 北京协和医院内分泌科，100005
摘要: 先天性肾上腺皮质增生症(congenital adrenal hyperplasia，CAH)是一种遗传代谢性疾病，21羟化酶缺乏型(21-OHD)是其中最常见的类型，约占90%。在世界范围 内典型的 21-OHD型发病率约为1 : 15 000，不典型的21-OHD型发病率约1 : 1 000，在某些民族甚至可以高达1 : 20 [1] 。现主要就CAH中21-OHD型患者终身 高方面的研究进展综述如下。 一、21-OHD患者的终身高情况 CAH中21-OHD患者的终身 高往往低于正常平均..
关键词：肾皮质；身高
HTML
PDF文献标引:冯韵霖，潘慧.先天性肾上腺皮质增生症21羟化酶缺乏型患者终身高的研究进展.中华临床医师杂志（电子版）,2007,1(5):438-440.
参考文献
[1] Merke D， Kabbani M. Congenital adrenal hyperplasia：epidemiology，management and practical drug treatment.Paediatr Drugs,2001,3(8)：599－611.[PubMed][2] Premawardhana LD， Hughes IA，Read GF，et al.Longer term outcome in females with congenital adrenal hyperplasia (CAH)：the Cardiff experience.Clin Endocrinol (Oxf),1997,46(3)：327－332.[PubMed]
[3] Eugster EA，Dimeglio LA，Wright JC，et al.Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency：a meta-analysis.J Pediatr,2001,138(1)：26－32.[PubMed]
[4] Jose Bernardo Q Quintos， Maria G Vogiatzi， Madeleine D Harbison ，et al.Growth hormone therapy alone or in combination with gonadotropin-Releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.The Journal of Clinical Endocrinology & Metabolism,2001,86(4)：1511－1517.[PubMed]
[5] Hedi L Claahsen-van der Grinten，Kees Noordam，George F Borm，et al.Absence of increased height velocity in the first year of life in untreated children with simple virilizing congenital adrenal hyperplasia.The Journal of Clinical Endocrinology & Metabolism,2006,91(4)：1205－1209.[PubMed]
[6] Karen Lin-Su，Maria G Vogiatzi，Ian Marshall，et al.Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia.The Journal of Clinical Endocrinology & Metabolism,2005,90(6)：3318－3325.[PubMed]
[7] Dacou-Voutetakis C， Karidis N. Congenital adrenal hyperplasia complicated by central precocious puberty：treatment with LHRH-agonist analogue.Ann N Y Acad Sci,1993,28(687)：250－254.[PubMed]
[8] Stikkelbroeck NM，Van't Hof-Grootenboer BA，Hermus AR，et al.Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency：in early infancy and (pre)puberty.J Clin Endocrinol Metab,2003,88(8)：3525－3530.[PubMed]
[9] Touati G，Prieur AM，Ruiz JC，et al.Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy I Effects on growth velocity and body composition.J Clin Endocrinol Metab,1998,83(2)：403－409.[PubMed]
[10] 田玉梅，叶军，韩连书，等.不同初治年龄对先天性肾上腺皮质增生症患儿发育的影响.中国实用儿科学杂志，2006,21：272－273.
[11] Allen DB，Julius JR，Breen TJ，et al.Treatment of glucocorticoid-induced growth suppression with growth hormone.National Cooperative Growth Study.J Clin Endocrinol Metab,1998,83(8)：2824－2829.[PubMed]
[12] Pucarelli I， Segni M， Ortore M， et al.Combined therapy with GnRH analog plus growth hormone in central precocious puberty.J Pediatr Endocrinol Metab,2000,13(Suppl 1)：811－820.[PubMed]
[13] Van Wyk JJ，Ritzen EM.The role of bilateral adrenalectomy in the treatment of congenital adrenal hyperplasia.J Clin Endocrinol Metab,2003,88(7)：2993－2998.[PubMed]
[14] Ogilvie CM，Rumsby G，Kurzawinski T，et al.Outcome of bilateral adrenalectomy in congenital adrenal hyperplasia：one unit's experience.Eur J Endocrinol,2006,154(3)：405－408.[PubMed]
[15] Meyers RL，Grua JR.Bilateral laparoscopic adrenalectomy：a new treatment for difficult cases of congenital adrenal hyperplasia.J Pediatr Surg,2000,35(11)：1586－1590.[PubMed]
[16] Charmandari E， Chrousos GP， Merke DP. Adrenocorticotropin hypersecretion and pituitary microadenoma following bilateral adrenalectomy in a patient with classic 21-hydroxylase deficiency.J Pediatr Endocrinol Metab,2005,18(1)：97－101.[PubMed]
[17] Forest MG.Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Hum Reprod Update,2004,10(6)：469－485.[PubMed]
[18] Lajic S，Nordenstr m A，Ritzén EM，et al.Prenatal treatment of congenital adrenal hyperplasia.Eur J Endocrinol,2004,151(Suppl 3)：U63－69.[PubMed]
[19] Varness TS， Allen DB， Hoffman GL.Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.J Pediatr,2005,147(4)：493－498.[PubMed]
[20] Votava F， Török D， Kovács J， et al. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.Eur J Endocrinol,2005,152(6)：869－874.[PubMed]
